CalciMedica Inc. (CALC)

Last Closing Price: 1.17 (2026-11-18)

Company Description

CalciMedica Inc. is a clinical-stage biopharmaceutical company. It focused on developing therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica Inc. is based in LA JOLLA, Calif.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-29.56M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.97
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -4239.00%
Return on Assets (Trailing 12 Months) -151.02%
Current Ratio (Most Recent Fiscal Quarter) 4.96
Quick Ratio (Most Recent Fiscal Quarter) 4.96
Debt to Common Equity (Most Recent Fiscal Quarter) 1.63
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.61
Earnings per Share (Most Recent Fiscal Quarter) $-0.72
Earnings per Share (Most Recent Fiscal Year) $-7.85
Diluted Earnings per Share (Trailing 12 Months) $-4.44
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 6.90M
Free Float 4.95M
Market Capitalization $8.41M
Average Volume (Last 20 Days) 0.08M
Beta (Past 60 Months) 0.84
Percentage Held By Insiders (Latest Annual Proxy Report) 28.25%
Percentage Held By Institutions (Latest 13F Reports) 0.00%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%